Trial Outcomes & Findings for High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery (NCT NCT05090852)

NCT ID: NCT05090852

Last Updated: 2022-10-13

Results Overview

For each case, the ability to complete the surgical procedure with use of only Hi-VNI device for oxygenation will be assessed. Patients were oxygenated with Hi-VNI at a flow rate of 40 L/min and FiO2 of 100%. Patients with spO2 \< 93 or TcCO2 \> 65 during the procedure were converted to an alternative means of oxygenation, including mask ventilation and endotracheal intubation. The primary outcome measure is the surgical case completion rate with or without converting to alternate means of oxygenation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

31 participants

Primary outcome timeframe

1 day

Results posted on

2022-10-13

Participant Flow

Participant milestones

Participant milestones
Measure
Hi-VNI as Primary or Adjunct Oxygenation Technique
Hi-VNI used as a primary or adjunct oxygenation technique during upper airway surgery Hi-VNI: Hi-VNI used instead of or along with endotracheal intubation or jet ventilation to provide oxygen to patients during upper airway surgery
Overall Study
STARTED
31
Overall Study
COMPLETED
26
Overall Study
NOT COMPLETED
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Hi-VNI as Primary or Adjunct Oxygenation Technique
Hi-VNI used as a primary or adjunct oxygenation technique during upper airway surgery Hi-VNI: Hi-VNI used instead of or along with endotracheal intubation or jet ventilation to provide oxygen to patients during upper airway surgery
Overall Study
Physician Decision
5

Baseline Characteristics

High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Hi-VNI as Primary or Adjunct Oxygenation Technique
n=31 Participants
Hi-VNI used as a primary or adjunct oxygenation technique during upper airway surgery Hi-VNI used instead of or along with endotracheal intubation or jet ventilation to provide oxygen to patients during upper airway surgery
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
24 Participants
n=99 Participants
Age, Categorical
>=65 years
7 Participants
n=99 Participants
Sex: Female, Male
Female
17 Participants
n=99 Participants
Sex: Female, Male
Male
14 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
23 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
8 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
4 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=99 Participants
Race (NIH/OMB)
White
17 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants
n=99 Participants
Region of Enrollment
United States
31 Participants
n=99 Participants

PRIMARY outcome

Timeframe: 1 day

Population: Adult patients undergoing upper airway surgery who received HVNI, We compared patients who successfully completed their anesthesia for the surgical case with HVNI vs patients who had to be intubated.

For each case, the ability to complete the surgical procedure with use of only Hi-VNI device for oxygenation will be assessed. Patients were oxygenated with Hi-VNI at a flow rate of 40 L/min and FiO2 of 100%. Patients with spO2 \< 93 or TcCO2 \> 65 during the procedure were converted to an alternative means of oxygenation, including mask ventilation and endotracheal intubation. The primary outcome measure is the surgical case completion rate with or without converting to alternate means of oxygenation.

Outcome measures

Outcome measures
Measure
Patients With HVNI and Patients With Intubation
n=31 Participants
Patients who completed their anesthesia with HVNI and patients who were switched to intubation
Surgical Case Completion Rate Using HVNI With or Without Converting to Alternative Mode of Oxygenation
Total number of patients who successfully received HVNI only
19 Participants
Surgical Case Completion Rate Using HVNI With or Without Converting to Alternative Mode of Oxygenation
Number of patients who received HVNI and also required conversion to alternate oxygenation
7 Participants
Surgical Case Completion Rate Using HVNI With or Without Converting to Alternative Mode of Oxygenation
Number of patients who were enrolled but did not receive HVNI
5 Participants

Adverse Events

Patients With HVNI and Patients With Intubation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Natasha Mirza, MD

UPenn

Phone: 215 662 2979

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place